Anthera Pharmaceuticals Inc 4
4 · Anthera Pharmaceuticals Inc · Filed Oct 13, 2015
Insider Transaction Report
Form 4
ODINK DEBRA
VP, Pharmaceutical R&D
Transactions
- Sale
Common Stock
2015-10-12$6.15/sh−1,205$7,411→ 7,896 total
Holdings
- 13,855(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2015.